share_log

Form 144 | 再生元制药公司(REGN.US)高管拟出售3,731股股份,价值约47.06万美元

Form 144 | Regeneron Pharmaceuticals(REGN.US) Officer Proposes to Sell 470.58K in Common Stocks

moomoo News ·  May 21 16:19

SEC FILLINGS DISCLOSED/ May 21, $Regeneron Pharmaceuticals (REGN.US)$ Officer LAROSA JOSEPH J intends to sell 3,731 shares of its common stock on May 21, with a total market value of approximately $470.58K.

LAROSA JOSEPH J has reduced shareholding in $Regeneron Pharmaceuticals (REGN.US)$ by 2,000 shares since Feb 22, 2024, with a total value of approximately $1.96 million.

1716322770802963575.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment